升红实验动物 | 11 Apr 2003 07:21
Favicon

动物血清

升红实验动物基地

    我基地长期生产各类动物血清,常年提供医用小白鼠\种苗\血清\鼠尸\小鼠血清\小鼠颌下腺等,其中以小鼠血清为主,月产量300升/月,
能确保长期、稳定、高质向各使用单位供应。

秉乘诚实、信义的良好商业道德,我们与各科研院校、医疗机构的数十余家实验室和数百余名科研工作者建立了非常良好的客户关系。 
如您对我基地产品很感兴趣,敬请联系,共同发展与合作!

产品描述: 

品名 小鼠血清   小鼠颌下腺  小鼠血浆   大鼠血清   大鼠血浆   兔血清 
单价 1.20元/ml  1.50元/对   1.00元/ml  1.00元/ml  1.00元/ml  1.00元/ml 

升红实验动物基地 
027-83864928  13026317555         周一~~周五  上午8:30-下午5:30
email: caidin <at> sina.com 
主页http://aidin.3322.net

http://shenhong.ecwin.net/
http://member.21bc.com/caidin/index.htm 

Laura Wood | 11 Apr 2003 19:29

Biotech & Genetics Industry Almanac

I enclose details of our Biotech & Genetics Industry Almanac.

Plunkett's Biotech & Genetics Industry Almanac is a complete reference guide to the business side of
biotechnology, genetics, proteomics and related services. This new book contains complete profiles of
the leading biotech companies, in-depth chapters on trends in biotech, technology, finances and
careers, a handy glossary and thorough indexes. 

New discoveries in biotech and genetics technologies will revolutionize health care in the early 21st
Century. Plunkett's Biotech & Genetics Industry Almanac, our easy-to-understand reference to the
biotech and genetics industry is an absolutely vital addition to your office. 

For the first time, in one carefully-researched volume, you'll get all of the data you need including:
complete basics, descriptions and statistics, research and development, growth companies,
proteomics, genomics, The Human Genome Project, emerging technology, international companies and
industry trends. Statistical tables include total patents, funding by source, R&D expenditures and
much more—a total of 15 major tables. 

The book also includes complete profiles on the "Biotech & Genetics 400," our own unique list of companies
that are the leaders in biotechnology. These are the 400 largest, most successful corporations in all
facets of this exploding business. All of the information is indexed and cross-indexed, including
contact names, addresses, Internet addresses, fax numbers, toll-free numbers, plus growth and hiring
plans, finances, research, marketing, technology, acquisitions and much more for each firm!
Purchasers of either the book or PDF version can request a free copy of the company profiles database on
CD-ROM, enabling export of contact names, addresses and more.
Reviews:

"…A book/CD-ROM reference guide to the business side of biotech, genetics, proteonics and related
services. Offers profiles of 400 leading biotech companies, plus overviews of trends in biotech,
technology, finances and careers which will help readers understand the uses and implications of such
technologies as tissue engineering, recombinant DNA and genetically engineered agricultural
(Continue reading)

WormBase | 12 Apr 2003 21:28
Favicon

WormBase release WS98 now online

This is an automatic announcement that WormBase
(http://www.wormbase.org) has just been updated.  New releases occur
roughly every 2 weeks.

The text of the AceDB release notes, which contains highlights of the
new data is attached.  You can download the full AceDB files from:

   ftp://ftp.sanger.ac.uk/pub/wormbase/current_release/

New Release of acedb WS98, Wormpep98 and Wormrna98 Fri Apr  4 17:02:42 BST 2003

======================================================================

This directory includes:
i)	database.WS98.*.tar.gz    -   compressed data for new release
ii)	models.wrm.WS98           -   the latest database schema (also in above database files)
iii)	CHROMOSOMES/subdir        -   contains 3 files (DNA, GFF & AGP per chromosome)
iv)	WS98-WS97.dbcomp          -   log file reporting difference from last release
v)	wormpep98.tar.gz          -   full Wormpep distribution corresponding to WS98
vi)	wormrna98.tar.gz          -   latest WormRNA release containing non-coding RNA's in the genome
vii)	confirmed_genes.WS98.gz   -   DNA sequences of all genes confirmed by EST &/or cDNA

Release notes on the web:
-------------------------
http://www.sanger.ac.uk/Projects/C_elegans/WORMBASE

Primary databases used in build WS98
------------------------------------
brigdb : 2003-03-07 - updated
camace : 2003-03-25 - updated
(Continue reading)

升红实验动物 | 17 Apr 2003 04:59
Favicon

动物血清

升红实验动物基地

    我基地长期生产各类动物血清,常年提供医用小白鼠\种苗\血清\鼠尸\小鼠血清\小鼠颌下腺等,其中以小鼠血清为主,月产量300升/月,
能确保长期、稳定、高质向各使用单位供应。

秉乘诚实、信义的良好商业道德,我们与各科研院校、医疗机构的数十余家实验室和数百余名科研工作者建立了非常良好的客户关系。 
如您对我基地产品很感兴趣,敬请联系,共同发展与合作!

产品描述: 

品名 小鼠血清   小鼠颌下腺  小鼠血浆   大鼠血清   大鼠血浆   兔血清 
单价 1.20元/ml  1.50元/对   1.00元/ml  1.00元/ml  1.00元/ml  1.00元/ml 

升红实验动物基地 
027-83864928  13026317555         周一~~周五  上午8:30-下午5:30
email: caidin <at> sina.com 
主页http://caidin.3322.net

http://shenhong.ecwin.net/
http://member.21bc.com/caidin/index.htm 

HR之白领世界 | 18 Apr 2003 15:27

4月26-27日,八千精英与300家知名企业将演义一群英雄与英雄的故事!!!

        2003
消毒 | 19 Apr 2003 13:20
Favicon

(unknown)

您好

主要特点:
1.杀菌范围广.高效杀灭肝炎病毒,结核杆菌,芽孢杆菌,金黄色葡萄球菌,
沙门氏菌,大肠杆菌,酵母菌,黑色变种牙孢,念珠菌,淋球菌,
梅毒黑曲霉等多种病菌:2.使用安全方便.该产品,
]
无色无味无毒,无刺激无腐蚀无残余不挥发具有良好的生物
降解效应不污染环境,对人体无副作用
3性质稳定,压抑菌期长,杀菌时不受蛋白质及有机物的干扰使用衰减期长,
可循环使用抑菌期长达14天
4.杀菌速度快.15秒--5分钟速效灭菌
重要成分
复合季铵类,复合醛类,螯合剂,表面活性剂,活性分子()
作用机理
复合季铵类与表面活性剂作用于细菌表面,
改变细菌的细胞膜的通透性.使得较大分子的复合季铵类进入细菌细胞内部,
与细菌的细胞质结合,使其变性,完成杀菌过程
 
 适用范围该产品广泛用于医院,制药工业,食品工业,水产,畜牧,种植,宾馆饭店
家庭,公共场的环境,器具和人体的消毒.对消除脚气,脚臭,腋臭,阴部瘙痒效果
明显;空间喷洒能够迅速消除各种异味,
清洁空气,有效的防止细菌病毒的交叉感染.
 因为现在非点形的病菌效多.请多小心.请来电联系,

配比型XB 500ml/瓶 批发价:68元 市场价:80元
配比型XB 5L/瓶    批发价:476元  市场价:560元
配比型XB 25L/瓶   批发价:1700元 市场价:2000元
联系人:杨先生  13049305783   0755-26530108-810
深圳帅浪实业有限公司
招商银行帐号:075529364396    03590532


 

Laura Wood | 20 Apr 2003 03:47

Pharmaceutical R&D Outsourcing Strategies: An Analysis of Market Drivers & Resistors to 2010

I enclose details of our latest Pharma R&D Outsourcing report.

Shareholder appetite for growth has not diminished, in stark contrast to the pharmaceutical industry's
ability to generate return on capital employed; while R&D and sales and marketing have traditionally
been held sacred as core competencies, the time has to come to reassess this assumption and the
alternative - outsourcing. 

Pharmaceutical R&D Outsourcing Strategies, a new report from Reuters Business Insight, provides
insights into effective outsourcing across the value chain, from drug discovery through to regulatory
submission. Through a series of case studies it outlines outsourcing best practice and it examines the
role of new technologies in increasing the effectiveness of R&D outsourcing. 

Based on an extensive programme of research, including interviews with senior pharmaceutical industry
executives, this new report from Reuters Business Insight presents a route map for high-performance outsourcing.

For a complete index of this report click on http://www.researchandmarkets.com/reports/4620

Report Index:

Pharmaceutical R&D Outsourcing strategies:
An analysis of market drivers and resistors to 2010

Shareholder appetite for growth has not diminished, in stark contrast to the pharmaceutical industry's
ability to generate return on capital employed. While R&D and sales and marketing
have traditionally been held sacred as core competencies, the time has to come to reassess this assumption
and the alternative - outsourcing. Pharmaceutical R&D Outsourcing Strategies, a new report from
Reuters Business Insight, provides insights into effective outsourcing across the value chain, from
drug discovery through to regulatory submission. Through a series of case studies it outlines
outsourcing best practice and it examines the role of new technologies in increasing the effectiveness
of R&D outsourcing. Based on an extensive programme of research, including interviews with senior
pharmaceutical industry executives, this new report from Reuters
Business Insight presents a route map for high-performance outsourcing.

Table of Contents

Executive Summary 8
Driving forces 8
Outsourcing R&D 9
The future of pharmaceutical outsourcing 10
Chapter 1 Driving Forces 14
Summary 14
Introduction 15
Increased focus on shareholder value 17
The productivity crisis in sales and marketing 18
The productivity crisis in R&D 19
Merger & Acquisition – the key to improving R&D productivity? 24
Measuring scale and R&D productivity 25
Is outsourcing the solution? 28
Chapter 2 Outsourcing R&D 34
Summary 34
Introduction 35
What is outsourcing? 35
CROs 36
Sizing the pharmaceutical R&D outsourcing market 37
The drivers and resistors for outsourcing R&D 41
Drivers of outsourcing 42
Rapid access to additional R&D capacity 43
Access to therapeutic expertise 44
Access to novel enabling technology 45
Case study: Roche gains access to genomics research through
agreement with deCode 46
Case study: Other examples of genomics agreements 47
Tighter focus on core competencies 48
Speed of development 48
Rapid access to patient populations for trial recruitment 50
Risk management 53
Is outsourcing cheaper? 53
The resistors of outsourcing R&D 55
Loss of in-house expertise 56
Lack of contact with investigators and opinion leaders 56
Loss of intellectual property/concerns over confidentiality 57
Loss of project control 59
Stability of CROs 59
The structure of the supplier base for outsourced R&D 60
Do pharmaceutical sponsors value one-stop-shopping? 67
Large versus small outsourcing vendors 72
Case study: Ilex Oncology completes transformation from specialist
CRO to pharmaceutical company 75
Outsourcing agreements 76
Fee-for-service 78
Risk-sharing agreements 79
Risk-sharing agreement case studies 81
Case study: PharmaBio Development invests in
Nitromed/Novia/Innapharma 81
Case study: PPD Discovery and Agouron enter risk-sharing
agreement 82
Facility-for-service/risk taking 83
Facility-for-service case studies 84
Case study: Quintiles leads the way with Aventis and Pharmacia
deals 84
Case study: Quest Diagnostics and SmithKline Beecham 85
Case study: MDS Pharma Services builds client specific facility for Sankyo 85
Conclusion 86
Defining optimum outsourcing strategies 87
Tactical versus strategic outsourcing 87
Defining a strategic outsourcing framework 89
Strategic outsourcing case studies 92
Case study: Biogen outsources development and commercialization
of Angiomax 92
Case study: Aventis shifts capital off the balance sheet 93
Forming best practice relationships with CROs 95
Distant relationships can be beneficial if managed effectively 95
Preferred supplier networks & strategic partnerships 96
Case study: Inceutica marketplace seeks CRO selection efficiencies 98
Case study: Kendle and Pharmacia 99
Improving outsourcing relationships 100
The role of eTechnology in outsourcing 102
Case study: Covance’s StudyTracker 105
Clinical trial patient recruitment on the Internet 106
Outsourcing online clinical trial recruitment 107
Case study: Acurian provides novel outsourced recruitment business
model 109
eDC 110
Outsourcing eDC 112
Case study: Eli Lilly invests in online trial venture with 1747 Inc. 115
In silico research 116
Outsourcing in silico research 117
Case study: Pharsight and Millenium 117
Chapter 3 The Future of Pharmaceutical
Outsourcing 120
Summary 120
Introduction 121
The outsourcing market to 2010 121
Forecast supplier base structure 124
Alternative long-term scenario 126
The virtual pharmaceutical model 127
The business model 127
Potential benefits of the virtual pharmaceutical model 128
Case study: Fulcrum (Protodigm) 130
Is the virtual business model realistic? 132
Virtual development providers – a new type of future outsourcing? 133
Conclusion 135
Chapter 4 Appendix 138
Pipeline productivity index 138
References 140
Index 142

List of Figures

Figure 1.1: The pharmaceutical industry outlook – investor concerns 16
Figure 1.2: Pharmaceutical R&D expenditure by US based companies, 1985–2001 20
Figure 1.3: Lengthening drug development timelines, 1960s–1990s 23
Figure 1.4: The commercial value of late stage R&D pipelines is directly proportional to R&D
expenditure 27
Figure 1.5: Opportunities to externalize activities throughout the pharmaceutical value chain 30
Figure 1.6: Global outsourcing expenditures, 1997–2000 32
Figure 2.7: The global pharmaceutical R&D outsourcing market, 1997–2001 39
Figure 2.8: Global pharmaceutical R&D outsourcing by stage, 2001 41
Figure 2.9: Drivers and resistors for outsourcing R&D 42
Figure 2.10: Ranking of drivers for outsourcing R&D 43
Figure 2.11: Outsourcing can add-value when resource needs fluctuate 44
Figure 2.12: Speed of development – in-house versus outsourced 50
Figure 2.13: Delays in clinical trial programs due to recruitment lags 51
Figure 2.14: Ranking of resistors to outsourcing R&D 55
Figure 2.15: Market share of the top 10 CROs, 2001 61
Figure 2.16: Indexed share performance of the top 5 CROs, January 1997–July 2002 65
Figure 2.17: The leading CROs’ service portfolios 68
Figure 2.18: The outsourcing R&D reality gap 71
Figure 2.19: The pros and cons of using large and small outsourcing vendors 73
Figure 2.20: Selecting the optimum agreement with CROs 77
Figure 2.21: Tactical versus strategic outsourcing 87
Figure 2.22: Building an effective strategic framework for outsourcing 91
Figure 2.23: Establishing best practice relationships with outsourcing providers 100
Figure 2.24: Multi-level relationship management with outsourcing providers 102
Figure 2.25: Drivers and resistors of outsourcing eClinical trial recruitment 109
Figure 2.26: The advantages of using eDC in clinical trials 112
Figure 3.27: The global pharmaceutical R&D outsourcing market, 2001–2010 124
Figure 3.28: The virtual pharmaceutical company transformation 128
Figure 3.29: Cost savings through adopting a virtual development approach 131

List of Tables:
Table 1.1: The declining productivity of R&D 21
Table 1.2: Pipeline productivity versus R&D spend 26
Table 2.3: The global pharmaceutical R&D outsourcing market, 1997– 2001 38
Table 2.4: Financial performance of the leading CROs, 2000–2001 62
Table 3.5: The global pharmaceutical R&D outsourcing market, 2001–2010 123
Table 4.6: Criteria and points used in generating Datamonitor’s pipeline productivity index 139

Report Pricing:
Electronic   EUR 1,283

ORDERING - 4 EASY WAYS TO PLACE YOUR ORDER:

Order online: To order this report please click on http://www.researchandmarkets.com/reports/4620
Order via email: mailto:orders <at> researchandmarkets.com
Order via fax-back form: Click on http://www.researchandmarkets.com/reports/4620 Fax to +353 14957318
Order via post: Click on http://www.researchandmarkets.com/reports/4620
Mail to Research and Markets Ltd., Guinness Centre, Taylors Lane, Dublin 8, Ireland

Related Reports Available from Research & Markets Ltd:

The US Bio-Chip Market for Pharmaceutical Drug Discovery: Technology, Strategic Alliance, Patent
Dispute and Market Update, 2002 - http://www.researchandmarkets.com/reports/291
Forecast of Pharmaceutical Market Opportunites to 2010 - http://www.researchandmarkets.com/reports/1323
The Pharmaceutical OTC Market to 2010 - http://www.researchandmarkets.com/reports/1231
The Pharmaceutical Outsourcing Database - Major Database of 1,321 Pharmaceutical Technology Providers
- http://www.researchandmarkets.com/reports/12124
U.S. Bio-Computing IT Market Bio-Computing + Pharmaceutical Companies, The Fusion of Computing and Drug
Discovery: Technologies, Products, Vendors, Opportunities and Market Forecasts  - http://www.researchandmarkets.com/reports/295
Biotechnology Business and Market Analysis - http://www.researchandmarkets.com/reports/16639
Respiratory Therapy European Market Survey: Analysis & Forecast - Technology, Sales & Company Profiles - http://www.researchandmarkets.com/reports/1336
A New Wave of IntraBiotech Alliances: A Company and Therapeutic Market Analysis - http://www.researchandmarkets.com/reports/1033
CNS Therapy Worldwide Market Survey: Analysis & Forecasts - Technology, Sales & Company Profiles - http://www.researchandmarkets.com/reports/1310
Cardiovascular Therapy Worldwide Market Survey: Analysis & Forecast - Technology, Sales & Company
Profiles - http://www.researchandmarkets.com/reports/1302
Pharmaceutical Innovation: An analysis of leading companies and strategies - http://www.researchandmarkets.com/reports/4622
Personalized Medicine: The Impact of Pharmacogenomics on Pharmaceutical R&D and Sales - http://www.researchandmarkets.com/reports/4610
Molecular Diagnostics: Transforming the Pharmaceutical Market - http://www.researchandmarkets.com/reports/4044
Maximizing R&D Productivity: Getting More Bang For Your R&D Buck - http://www.researchandmarkets.com/reports/862
Sci-fi to Sci-fact –  Market Opportunities for Point  of Care DNA Testing Devices - http://www.researchandmarkets.com/reports/19858
Therapeutic and Pharmaceutical Opportunities for Osteoporosis and Atherosclerosis - http://www.researchandmarkets.com/reports/19801
Pharmaceutical Strategic Alliances: Benchmarking 21st century deal-making - http://www.researchandmarkets.com/reports/6547
Drugs of Tomorrow 2001: Antipsychotics - New Players in an Expanding Market - http://www.researchandmarkets.com/reports/857

Click on http://www.researchandmarkets.com for details.

Thank you for your consideration.

Kind Regards,

Laura Wood
Senior Manager
Research and Markets Ltd
laura.wood <at> researchandmarkets.com

REPORT DATA SUMMARY:
Pharmaceutical R&D Outsourcing Strategies: An analysis of market drivers and resistors to 2010
Publisher Name: Reuters Business Insight
Date Published: 9/1/2002
Category: Biotechnology
URL: www.researchandmarkets.com/reports/4620

Subscribe: Click on http://www.researchandmarkets.com/register.asp You can subscribe free for
regular details on new research in your sector.

If you no longer wish to receive our market research updates, please reply to this message with
"Suppression Request" as the subject line, or email a blank email to suppressed <at> researchandmarkets.com

Laura Wood | 22 Apr 2003 18:33

InfoBase CD-ROM Directory of 12,000 Life Science Companies and Organizations

I enclose details of our latest Biotechnology CD-Rom with over 12,000 companies across the sector.

Locate your best potential customers and partners with the newly updated BioZak InfoBase CD-ROM
directory of 12,000 science companies and organizations worldwide.

Each record contains:
- Address, City, Zip Code
- Phone, fax number
- Industry Category
- Internet URL
- Email
- Number of employees
- Revenue 

Features:
- Search by industry sector, company size, geography
- Export results to Microsoft Office for easy mailings
- Auto-installs in seconds
- Simple to use
- Includes contact info (including email) 

Industry Category Breakdown - CD-ROM data

Category & Number of Companies:

Animal Health 218 
Biopharmaceuticals 770 
Biotechnology 4227 
    Bioinformatics 206 
    Biomaterials 227 
    Combinatorial Chemistry 50 
    Drug Discovery 472 
    Gene Therapy 115 
    Genomics 202 
    High Throughput Screening 85 
    Other 410 
    Proteomics 97 
    Research Equipment 1143 
    Research Supplies 1439 
Diagnostics 1576 
    Diagnostic Equipment 895 
    Diagnostic Tests 689 
Drug Delivery 313 
    Intravesical 2 
    Lung 24 
    Nasal 13 
    Ophthalmic 6 
    Oral 52 
    Other 119 
    Topical 45 
HealthCare 102 
Medical Devices 815 
    Therapeutic - personal use 498 
    Therapeutic equipment 338 
Pharmaceutical 861 
Service Providers 5425 
    Consultants 752 
    Contract Research 1061 
    Distribution 288 
    Event Management 26 
    Financial 426 
    Generic Supplies 235 
    Industry Associations 177 
    Information Services 533 
        Drug Information 33 
        Industry News Sources 141 
        Medical Information 128 
    Intellectual Property/Legal 201 
    Other 809 
    Professional Societies 139 
    Recruitment 419 
    Regulatory 130 
    Software 520 
    Technology Transfer 254 

For more details on this product click on http://www.researchandmarkets.com/reports/17424

Report Pricing:
CD-ROM   EUR 851

ORDERING - 4 EASY WAYS TO PLACE YOUR ORDER:

Order online: To order this report please click on http://www.researchandmarkets.com/reports/17424
Order via email: mailto:orders <at> researchandmarkets.com
Order via fax-back form: Click on http://www.researchandmarkets.com/reports/17424 Fax to +353 14957318
Order via post: Click on http://www.researchandmarkets.com/reports/17424
Mail to Research and Markets Ltd., Guinness Centre, Taylors Lane, Dublin 8, Ireland

Related Reports Available from Research & Markets Ltd:

InfoBase CD-ROM Directory of 6,000+ Service Providers to the Life Sciences Industry - http://www.researchandmarkets.com/reports/17426
InfoBase CD-ROM Directory of 6,000+ Biotechnology, Pharmaceutical & Medical Devices Companies - http://www.researchandmarkets.com/reports/17425
Service and Support for Life Science Products: Creating Loyal Customers - http://www.researchandmarkets.com/reports/10745
Brand Awareness in the Life Science Market - http://www.researchandmarkets.com/reports/10740
Leading Companies in the Life Service & Vitamin Industry - http://www.researchandmarkets.com/reports/6130
Pharmaceutical Promotional Effectiveness: Benchmarking Top Tier Companies by Country, Channel,
Therapy Area and ROI - http://www.researchandmarkets.com/reports/6531
Advertising to Life Scientists - http://www.researchandmarkets.com/reports/10755
Maximizing Investment of Returns: Analysis of Ethical Sales Growth and Asset Allocation Trends Within
the Leading US and EU Pharmaceutical Companies - http://www.researchandmarkets.com/reports/4536
Pharmaceutical Companies and Technology Vendors: Partners in eBusiness Implementation - http://www.researchandmarkets.com/reports/4511
Top 50 Pharmaceutical Companies in the US: A Competitive Analysis (2001 Edition, Vol. 1) - http://www.researchandmarkets.com/reports/1333
Facing HIPAA - What Pharmaceutical Companies Need to Know - http://www.researchandmarkets.com/reports/996
Directory of Medical & Behavioral Healthcare Websites - http://www.researchandmarkets.com/reports/1923
Marketing to Life Scientists: A Comparison of the Industrial and Academic Segments - http://www.researchandmarkets.com/reports/10746
Targeting an eHealth Audience: What Pharmaceutical Companies Need to Know About Physicians, Consumers
and the Internet - http://www.researchandmarkets.com/reports/924
Life Medical Sciences - http://www.researchandmarkets.com/reports/10469

Click on http://www.researchandmarkets.com for details.

Thank you for your consideration.

Kind Regards,

Laura Wood
Senior Manager
Research and Markets Ltd
laura.wood <at> researchandmarkets.com

REPORT DATA SUMMARY:
InfoBase CD-ROM Directory of 12,000 Life Science Companies and Organizations
Publisher Name: BioZak
Category: Biotechnology
URL: www.researchandmarkets.com/reports/17424

Subscribe: Click on http://www.researchandmarkets.com/register.asp You can subscribe free for
regular details on new research in your sector.

If you no longer wish to receive our market research updates, please reply to this message with
"Suppression Request" as the subject line, or email a blank email to suppressed <at> researchandmarkets.com

Laura Wood | 23 Apr 2003 21:04

Global Biocide Report

I enclose details of our latest biocides report.

The World consumption of Biocides is estimated at $ 3,380 million at active manufacture  level, 12 %
growth over the last three years.  

Taking the Asian crisis into consideration, this is an impressive performance which is governed by end
industry growth, technological developments, regulatory changes and the growing use of Biocides as an
aid to improved hygiene. 

Biocide Information Services (BIS) analyses each of these developments by specific end-user industry
and their likely impact, according to three geographical areas (North America, Western Europe and Rest
of the World).  In addition, the GLOBAL BIOCIDES REPORT provides detailed marketing data regarding
Biocides, major applications, suppliers and customers.  

MULTICLIENT STUDIES: BIOCIDES IN SELECTED GEOGRAPHICAL REGIONS

Objectives:
To provide Marketing data on biocides, major biocide applications, suppliers and customers. 

To identify and analyse the trends taking place within the biocide industry. 

Contents of Study: 
- Comprehensive overview of 17 end user industries and biocides used. 
- Profile of 36 biocide suppliers. 
- Analysis of 9 largest chemical families used as biocides. 
- Margin analysis for biocides at each level along supply chain. 
- Summary of the regulatory requirements and pending legislation. 
- Consumption of biocides expressed at manufacture level and end user level. 
- 400+ pages 

Methodology: 
300 in-depth interviews with end users, suppliers and formulators. 
Other sources of information, e.g., Biocides Reporting Service. 
Accuracy 
BIS believes that our estimates are within 10% of actual values. 

Feedback from Multiclient Studies: 
"Presentation is excellent ... the data is presented in the form of tables and charts, making key facts
visible at a glance." 
"The information has been gathered from a wide variety of sources, which ensures a complete and accurate
picture." 
"Different from other multiclient studies due to the strong end-user focus. This gives it a high degree of
credibility." 
"The study correlates with what we know in the industries that we participate in. This makes it useful for
our strategic plans." 

Objectives: 
The guide details information on over 1,500 specialty biocides. The type of information provided is as
follows: 
Product or Trade Name 
Active Ingredient(s) 
Product Description (Liquid / Powder, Typical Formulations) 
End-use Applications 
Suppliers Name, Address & Contact 

For a complete index of this report click on http://www.researchandmarkets.com/reports/19818

Report Index:

Chapter - End-User Industry 
1  Adhesives
2  Antiseptics and Contact Lenses
3  Cooling Water 
4  Household Products 
5  Industrial and Institutional Products 
6  Inks 
7  Leather 
8  Metalworking Fluids 
9  Mineral Slurries 
10 Paints 
11 Paper 
12 Personal Care 
13 Petroleum Production 
14 Plastics 
15 Polymer Emulsions 
16 Recreational Water 
17 Textiles 
18 Wood Preservatives 

The following is the table of contents for the report which is available for immediate dispatch by
electronic or via hard copy. 

EXECUTIVE SUMMARY 

1.	BIOCIDES IN ADHESIVES	CHAPTER 1
	GLOBAL SUMMARY	
	BIOCIDES IN ADHESIVES - NORTH AMERICA	CHAPTER 1.1
	BIOCIDES IN ADHESIVES - WESTERN EUROPE	CHAPTER 1.2
	BIOCIDES IN ADHESIVES - REST OF WORLD	CHAPTER 1.3
2.	BIOCIDES IN ANTISEPTICS & CONTACT LENSES	CHAPTER 2
	GLOBAL SUMMARY	
	BIOCIDES IN ANTISEPTICS - NORTH AMERICA	CHAPTER 2.1
	BIOCIDES IN ANTISEPTICS - WESTERN EUROPE	CHAPTER 2.2
	BIOCIDES IN ANTISEPTICS - REST OF WORLD	CHAPTER 2.3
3.	BIOCIDES IN COOLING WATER	CHAPTER 3
	GLOBAL SUMMARY	
	BIOCIDES IN COOLING WATER - NORTH AMERICA	CHAPTER 3.1
	BIOCIDES IN COOLING WATER - WESTERN EUROPE	CHAPTER 3.2
	BIOCIDES IN COOLING WATER - REST OF WORLD	CHAPTER 3.3
4.	BIOCIDES IN HOUSEHOLD PRODUCTS	CHAPTER 4
	GLOBAL SUMMARY	
	BIOCIDES IN HOUSEHOLD PRODUCUTS - NORTH AMERICA	CHAPTER 4.1
	BIOCIDES IN HOUSEHOLD PRODUCUTS - WESTERN EUROPE	CHAPTER 4.2
	BIOCIDES IN HOUSEHOLD PRODUCUTS - REST OF WORLD	CHAPTER 4.3
5.	BIOCIDES IN INDUSTRIAL & INSTITUTIONAL PRODUCTS	CHAPTER 5
	GLOBAL SUMMARY	
	BIOCIDES IN INDUSTRIAL & INSTITUTIONAL - NORTH AMERICA	CHAPTER 5.1 
	BIOCIDES IN INDUSTRIAL & INSTITUTIONAL - WESTERN EUROPE	CHAPTER 5.2 
	BIOCIDES IN INDUSTRIAL & INSTITUTIONAL - REST OF WORLD	CHAPTER 5.3 
6.	BIOCIDES IN INKS	CHAPTER 6
	GLOBAL SUMMARY	
	BIOCIDES IN  INKS - NORTH AMERICA	CHAPTER 6.1
	BIOCIDES IN  INKS - WESTERN EUROPE	CHAPTER 6.2
	BIOCIDES IN  INKS - REST OF WORLD	CHAPTER 6.3
7.	BIOCIDES IN LEATHER	CHAPTER 7
	GLOBAL SUMMARY	
	BIOCIDES IN  LEATHER - NORTH AMERICA	CHAPTER 7.1
	BIOCIDES IN  LEATHER - WESTERN EUROPE	CHAPTER 7.2
	BIOCIDES IN  LEATHER - REST OF WORLD	CHAPTER 7.3
8.	BIOCIDES IN METALWORKING FLUIDS	CHAPTER 8
	GLOBAL SUMMARY	
	BIOCIDES IN METALWORKING FLUIDS - NORTH AMERICA	CHAPTER 8.1
	BIOCIDES IN METALWORKING FLUIDS - WESTERN EUROPE	CHAPTER 8.2
	BIOCIDES IN METALWORKING FLUIDS - REST OF WORLD	CHAPTER 8.3
9.	BIOCIDES IN MINERAL SLURRIES	CHAPTER 9
	GLOBAL SUMMARY	
	BIOCIDES IN MINERAL SLURRIES - NORTH AMERICA	CHAPTER 9.1
	BIOCIDES IN MINERAL SLURRIES - WESTERN EUROPE	CHAPTER 9.2
	BIOCIDES IN MINERAL SLURRIES - REST OF WORLD	CHAPTER 9.3
10.	BIOCIDES IN PAINTS	CHAPTER 10
	GLOBAL SUMMARY	
	BIOCIDES IN PAINTS - NORTH AMERICA	CHAPTER 10.1
	BIOCIDES IN PAINTS - WESTERN EUROPE	CHAPTER 10.2
	BIOCIDES IN PAINTS - REST OF WORLD	CHAPTER 10.3
11.	BIOCIDES IN PAPER	CHAPTER 11
	GLOBAL SUMMARY	
	BIOCIDES IN PAPER - NORTH AMERICA	CHAPTER 11.1
	BIOCIDES IN PAPER - WESTERN EUROPE	CHAPTER 11.2
	BIOCIDES IN PAPER - REST OF WORLD	CHAPTER 11.3
12.	BIOCIDES IN PERSONAL CARE	CHAPTER 12
	GLOBAL SUMMARY	
	BIOCIDES IN PERSONAL CARE - NORTH AMERICA	CHAPTER 12.1
	BIOCIDES IN PERSONAL CARE - WESTERN EUROPE	CHAPTER 12.2 
	BIOCIDES IN PERSONAL CARE - REST OF WORLD	CHAPTER 12.3 
13.	BIOCIDES IN PETROLEUM PRODUCTION	CHAPTER 13
	GLOBAL SUMMARY	
	BIOCIDES IN PETROLEUM PRODUCTION - NORTH AMERICA	CHAPTER 13.1
	BIOCIDES IN PETROLEUM PRODUCTION - WESTERN EUROPE	CHAPTER 13.2 
	BIOCIDES IN PETROLEUM PRODUCTION - REST OF WORLD	CHAPTER 13.3 
14.	BIOCIDES IN PLASTICS	CHAPTER 14
	GLOBAL SUMMARY	
	BIOCIDES IN PLASTICS - NORTH AMERICA	CHAPTER 14.1
	BIOCIDES IN PLASTICS - WESTERN EUROPE	CHAPTER 14.2
	BIOCIDES IN PLASTICS - REST OF WORLD	CHAPTER 14.3
15.	BIOCIDES IN POLYMER EMULSIONS	CHAPTER 15
	GLOBAL SUMMARY	
	BIOCIDES IN POLYMMER EMULSIONS - NORTH AMERICA	CHAPTER 15.1
	BIOCIDES IN POLYMMER EMULSIONS - WESTERN EUROPE	CHAPTER 15.2
	BIOCIDES IN POLYMMER EMULSIONS - REST OF WORLD	CHAPTER 15.3
16.	BIOCIDES IN RECREATIONAL WATER	CHAPTER 16
	GLOBAL SUMMARY	
	BIOCIDES IN RECREATIONAL WATER - NORTH AMERICA	CHAPTER 16.1
	BIOCIDES IN RECREATIONAL WATER - WESTERN EUROPE	CHAPTER 16.2
	BIOCIDES IN RECREATIONAL WATER - REST OF WORLD	CHAPTER 16.3
17.	BIOCIDES IN TEXTILES	CHAPTER 17
	GLOBAL SUMMARY	
	BIOCIDES IN TEXTILES - NORTH AMERICA	CHAPTER 17.1
	BIOCIDES IN TEXTILES - WESTERN EUROPE	CHAPTER 17.2
	BIOCIDES IN TEXTILES - REST OF WORLD	CHAPTER 17.3
18.	BIOCIDES IN WOOD PRESERVATIVES	CHAPTER 18
	GLOBAL SUMMARY	
	BIOCIDES IN WOOD PRESERVATIVES - NORTH AMERICA	CHAPTER 18.1 
	BIOCIDES IN WOOD PRESERVATIVES - WESTERN EUROPE	CHAPTER 18.2
	BIOCIDES IN WOOD PRESERVATIVES - REST OF WORLD	CHAPTER 18.3

The World consumption of Biocides is estimated and analysed for 18 applications. The objectives of the
report are:

- To provide marketing data on biocides, major applications, suppliers and end-users.

- To identify the regulatory requirements and analyse the trends taking place. 

Each of the 18 application’s is profiled under the following headings:

- Biocide consumption in value and volume
- Biocide comparison
- Distribution analysis
- End application profile
- Biocide supplier sales
- Main trends occurring
- Outlook for the future

The Biocide industry is governed by end industry growth, technological developments, regulatory
changes and the growing use of Biocides as an aid to improved hygiene. 

Biocide Information Services (BIS) analyses each of these developments by specific end-user industry
and their likely impact. In addition, the report provides detailed marketing data regarding Biocides,
major applications, suppliers, global geographical regions and customers. The report is over 480 pages
and also includes a quantitative report based on biocide consumption by application, by supplier and by
geographical region.

We believe that our extensive knowledge of the Biocides industry, combined with our professional staff
means we are uniquely qualified to provide this report. The data used in the report was drawn from our
databases, extensive customer interviews and confirmed by Biocide suppliers across the globe. 

The following are summary and table of contents for the report. 

SUMMARY OF THE GLOBAL BIOCIDES INDUSTRY

The global consumption of biocides was $ 3,107 million in 2002, 40 % growth on 1992. This impressive
performance reflects not only end industry growth, regulatory and technological changes but also the
growing use of biocides as hygiene aids in a broad range of applications. Biocide Information Services
(BIS) analyses the reasons for this changing market and provides detailed marketing data regarding
biocides, major applications, suppliers and customers by geographical region. Attached is the table of
contents for the report.

We believe that our extensive knowledge of the biocides industry, combined with our professional staff
means we are uniquely qualified to provide this report. The data used in the report was drawn from our
databases, extensive customer interviews and confirmed by biocide suppliers and service companies. 

Objectives

The key objectives of this study were:

1. To provide marketing data on biocides, major biocide applications, suppliers and customers.
2. To identify and analyse the trends taking place within the biocides industry.
3. To define the regulatory and distribution channels in the industry.

Methodology

The report is based on over 400 interviews conducted throughout the globe. In each industry analysis, BIS
contacted end-users, biocide manufacturers, suppliers, distributors and trade associations by
telephone and conducted unstructured interviews typical of the type used in industrial market
research. 

In addition to interviews, the report also summarises suppliers product literature, data from trade
associations, BIS databases and our monthly information report.

APPROACH

1. To obtain the information desired, BIS completed a comprehensive analysis of the global Biocides
industry. This included interviews carried out by telephone with end-users, preservative suppliers
and industry associations. 

The work was performed from the BIS offices in Dublin, Ireland using the following interviewees for
respective geographical regions.

RESEARCHERS RESPONSIBLE FOR CARRYING OUT THE RESEARCH

COUNTRY			BIS PERSONNEL 
Africa			David Pierse	
Americas		Sara Garcia Nieto 
Asia			Musrizal Muin
France  		Anne Ouvrard
Asia (Excl Japan)	Made Agus
Italy			Maurizio Zenari
Japan			Maiko Tasankuri
Rest of Europe		Marianne Azema	
Spain			Angel Arino
Coordinator		Niall D'Arcy

Accuracy of the information

BIS believes our estimates to be within 20 % of the actual value. The accuracy of the information is
dependent on many factors such as the number of interviews conducted per end industry, industry
concentration and industry usage patterns. In order to increase our accuracy, BIS increases the number
of end-user interviews where an industry is fragmented and continued to interview until there is
similarity in responses. Also all conclusions and data per industry were confirmed with the key
manufacturers of biocides. 

Definitions

Biocide manufacturers are defined as companies whose majority of sales comes from manufacturing actives
in-house. For example Albermarle, Arch, Avecia, Buckman, Clariant, Dow, Great Lakes, Lonza, Rohm & Haas
and Troy.

Biocide Blenders / Service Companies are defined as companies whose majority of sales comes from
purchasing biocides which they blend into their own products. For example Ecolab, GEBetzDearborn,
Nalco etc.

Distributors act as agents for both active manufacturers and biocide blenders. They are the most popular
choice of supplier for small end-users. Distributors sell a range of industrial additives and so will be
making deliveries to end users and therefore biocides tend to be combined with other products which
allows the distributor to be competitive. 

Prices are in U.S. dollars and are at active manufacturer level unless stated.

Volumes are reported in tonnes based on a 100 % active biocide basis. In the case of formulated products, the
data is reported with a typical percentage of the formulated product.

REASON FOR PURCHASING REPORTS 

1. The reports offers comprehensive data on products, major application uses and market trends. This
increases your market knowledge and allows you to plan proactively.

2. Reports are highly focused with a minimum of 20 multinational end-users interviewed per application.
All data & trends identified within the reports, have been confirmed by the leading biocide suppliers.

3. The reports are written by biocide industry specialists. We believe that our extensive knowledge of the
biocides industry, combined with our professional staff means we are uniquely qualified to provide such
reports.  

4. All reports offer assessments of current suppliers and their products. This helps you to analyse your
competitors and position your products in appropriate market niches.

5. The report discusses the Biocides Product Directive ( BPD ). This allows you to increase your
understanding of the implications of the BPD and will enable you to do proactive planning.

6. Reports are updated periodically using information from our contacts with the biocide industry. In
addition, updated data is continually being generated from our monthly Biocides Reporting Service.

Report Pricing:

Hard Copy   EUR 10,700
Electronic   EUR 10,700

ORDERING - 4 EASY WAYS TO PLACE YOUR ORDER:

Order online: To order this report please click on http://www.researchandmarkets.com/reports/19818
Order via email: mailto:orders <at> researchandmarkets.com
Order via fax-back form: Click on http://www.researchandmarkets.com/reports/19818 Fax to +353 14957318
Order via post: Click on http://www.researchandmarkets.com/reports/19818
Mail to Research and Markets Ltd., Guinness Centre, Taylors Lane, Dublin 8, Ireland

Thank you for your consideration.

Kind Regards,

Laura Wood
Senior Manager
Research and Markets Ltd
laura.wood <at> researchandmarkets.com

REPORT DATA SUMMARY:
Global Biocide Report
Publisher Name: Biocide Information Services (BIS)
Date Published: 30/03/03
Number of Pages: 400
URL: www.researchandmarkets.com/reports/19818

Subscribe: Click on http://www.researchandmarkets.com/register.asp You can subscribe free for
regular details on new research in your sector.

If you no longer wish to receive our market research updates, please reply to this message with
"Suppression Request" as the subject line, or email a blank email to suppressed <at> researchandmarkets.com

Sadler, Penny (NIH/NIDDK | 24 Apr 2003 23:22
Picon
Picon

Question about cyclin B nomenclature

Dear Wormbase,
I was wondering if you could explain why cyb-2 is renamed cyb-2.1. Is there
a reference associated with the name change?
There is a bracketed set of numbers/letters [020808 krb] associated with the
new name but I am having a diffucult time determining their significance. 
Thank you for your assistance,
Penny Sadler


Gmane